Description
Mutations, Fusion, PD-L1 (22C3), and MSI Analysis
Tissue, NA, Fasting or Non Fasting: As suggested by doctor
Sample Required:
FFPE lung tumour tissue block OR fresh tissue in DCGL Preservative Solution at 2–8°C; tumour content >10%.
Test Time:
Biopsy-dependent. 8–12 working days.
Test Normal Range:
No fixed normal range.
What is the Test?
A combined NGS + IHC panel assessing **12 genes**, PD-L1 (22C3) and **MSI** status for comprehensive lung cancer profiling.
Test Procedure:
Tumour tissue undergoes sequencing plus IHC for PD-L1 and MSI evaluation.
When to Take the Test:
When both molecular and immunotherapy markers are needed simultaneously.
Who Should Take This Test:
Patients needing complete lung cancer profiling for advanced therapy planning.
Precautions for Exceptional Cases (Pregnancy, etc.):
Ensure tumour adequacy; inform doctor of pregnancy status.
